Menu Search
Equities

USANA Health Sciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
USJ:BRN

USANA Health Sciences Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta0.6086
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

  • Revenue in USD (TTM)876.24m
  • Net income in USD34.90m
  • Incorporated1992
  • Employees1.70k
  • Location
    USANA Health Sciences Inc3838 West Parkway Blvd.SALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		USNA:NYQ since
announced		Transaction
value
Hiya Health Products LLCDeal completed23 Dec 202423 Dec 2024Deal completed-9.08%205.00m
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.